Differential alternative splicing between hepatocellular carcinoma with normal and elevated serum alpha-fetoprotein

BACKGROUND: Serum alpha-fetoprotein (AFP) is the approved serum marker for hepatocellular carcinoma (HCC) screening. However, not all HCC patients show high (≥ 20 ng/mL) serum AFP, and the molecular mechanisms of HCCs with normal (< 20 ng/mL) serum AFP remain to be elucidated. Therefore, we aimed...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Young-Joo, Aycheh, Habtamu Minassie, Han, Seonggyun, Chamberlin, John, Shin, Jaehang, Byun, Seyoun, Lee, Younghee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7771076/
https://www.ncbi.nlm.nih.gov/pubmed/33371894
http://dx.doi.org/10.1186/s12920-020-00836-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7771076/
https://www.ncbi.nlm.nih.gov/pubmed/33371894
http://dx.doi.org/10.1186/s12920-020-00836-4

Ejemplares similares